Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 67 pseudogene (RNU7-67P) is classified as a pseudogene, specifically annotated as a "U7 small nuclear" RNA pseudogene[4][5][6][8][9]. It does not encode a functional product and is not involved in the canonical biological processes attributed to the functional U7 small nuclear RNA, which is important in histone pre-mRNA processing[1]. There is no evidence supporting this pseudogene as a therapeutic target, nor is it associated with direct biological functions, disease mechanisms, or known drug interactions. Its classification as a "pseudogene" means it is likely a non-functional genomic sequence derived from a once-functional gene[5][8][9]. The entry is not a true target and is not therapeutically actionable. Notes: - The functional gene in this family is RNU7-1; RNU7-67P is a non-functional pseudogene. - There are no known molecular functions, disease roles, biomarkers, or drugs associated with RNU7-67P. - Listing this as a *target* is incorrect and indicates a likely data error or overspecification[5][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 67 pseudogene (RNU7-67P).